Source link : https://newshealth.biz/health-news/palopegteriparatide-benefits-sustained-beyond-3-years/
Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements. Medscape Medical News Source link : https://www.medscape.com/viewarticle/phase-3-palopegteriparatide-results-show-sustained-benefits-2026a1000jyi?src=rss Author : Publish date : 2026-06-14 17:43:00 Copyright for syndicated content belongs to the linked Source.
The post Palopegteriparatide Benefits Sustained Beyond 3 Years first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-14 17:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8